Jade Biosciences, Inc. (JBIO) Misses Q2 EPS by 55c

Jade Biosciences, Inc. (NASDAQ: JBIO) reported Q2 EPS of ($0.86), $0.55 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Jade Biosciences, Inc. (JBIO) click here.

You May Also Be Interested In

• PG&E Corp, Edison Spike; California Assembly Won't Take Vote On Utility Wildfire Bill
• Amazon (AMZN) call put ratio 1.6 calls 1 put as share price down 2.1%
• Iranian missiles, drones fired toward enemy positions - Fars